FOUNDER SPOTLIGHT
ERNEST GARCIA, MD
Scientific Founder and Chief Scientific Advisor, Syntermed Inc. /
Professor of Radiology, Emory University School of Medicine
“Federal funding provided the scientific resources needed to develop useful clinical tools, and with additional funding, the tools were later developed into products licensed by Syntermed to benefit cardiac patients everywhere, not just at Emory. Having these products originate from the needs of clinicians, and developed by scientists who are constantly interacting in the clinical environment, is a winning formula for successful clinical tools.”
FAST FACTS
FOUNDER(S):
Dr. Ernest Garcia
INNOVATION(S):
Medical Imaging Technologies
EMPLOYEES:
5
HEADQUARTERS:
Atlanta, GA
FOUNDED:
1999
REVENUE:
$3 million FY08
TSC MEMBER INSTITUTION(S):
Emory University
FUNDING AGENCY(S):
National Institutes of Health
STATUS:
Private
|
SYNTERMED, INC.
SOFTWARE SOLUTIONS FROM MEDICAL IMAGING
ABOUT THE COMPANY:
Syntermed, Inc. is an Atlanta-based nuclear medicine imaging and informatics software company. The company’s lead product is a software package called Emory Cardiac ToolboxTM (ECTbTM). Today, the Emory Cardiac Toolbox is in nearly half of all nuclear medicine labs nationwide.
Syntermed’s software products were developed by Emory University scientist Ernest Garcia, PhD and his colleagues, in collaboration with scientists at the Georgia Institute of Technology. The Emory Cardiac Toolbox provides physicians with the ability to process, display, interpret, and analyze cardiac positron emission tomography (PET) and single-photon computed tomography (SPECT) images. By displaying three-dimensional images of the patient’s heart, the Toolbox allows physicians to see whether or not blood is flowing to all areas of the myocardium and determine the heart’s efficiency.
UNIVERSITY-BASED RESEARCH CONNECTION:
Emory University initially licensed these software packages directly to equipment manufacturers and diagnostic imaging centers. In 1999, Syntermed was co-founded by the Emory University Office of Technology Transfer in order to streamline the commercialization of the university-developed software products, and Syntermed now does direct licensing.
ROLE OF FEDERAL RESEARCH FUNDING:
The research and product development was supported by grants from the National Institutes of Health and the Georgia Research Alliance, a state agency.
 Read The Full Report Here
|
Printer-Friendly Version
SYNTERMED, INC.